Connection

Antonio Gasbarrini to Anti-Bacterial Agents

This is a "connection" page, showing publications Antonio Gasbarrini has written about Anti-Bacterial Agents.
Connection Strength

0.862
  1. Antibiotic and Modulation of Microbiota: A New Paradigm? J Clin Gastroenterol. 2018 Nov/Dec; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S74-S77.
    View in: PubMed
    Score: 0.158
  2. Considering gut microbiota disturbance in the management of Helicobacter pylori infection. Expert Rev Gastroenterol Hepatol. 2018 Sep; 12(9):899-906.
    View in: PubMed
    Score: 0.155
  3. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol. 2017 Jul 07; 23(25):4491-4499.
    View in: PubMed
    Score: 0.144
  4. How to modulate gut microbiota: diet, preprobiotics or antibiotics? Minerva Gastroenterol Dietol. 2017 Dec; 63(4):411-419.
    View in: PubMed
    Score: 0.140
  5. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6379-6386.
    View in: PubMed
    Score: 0.041
  6. Spondylodiscitis: is really all well defined? Eur Rev Med Pharmacol Sci. 2019 Apr; 23(2 Suppl):201-209.
    View in: PubMed
    Score: 0.041
  7. Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(1):426-430.
    View in: PubMed
    Score: 0.040
  8. Clinical assessment and management of severe acute pancreatitis: a multi-disciplinary approach in the XXI century. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):771-787.
    View in: PubMed
    Score: 0.040
  9. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018 07; 48(2):152-159.
    View in: PubMed
    Score: 0.038
  10. Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol. 2018 05; 53(5):567-572.
    View in: PubMed
    Score: 0.037
  11. [Microbiota and inflammatory bowel disease: an update.] Recenti Prog Med. 2018 Dec; 109(12):570-573.
    View in: PubMed
    Score: 0.010
  12. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Aliment Pharmacol Ther. 1998 Jun; 12(6):539-43.
    View in: PubMed
    Score: 0.010
  13. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Dig Liver Dis. 2018 08; 50(8):741-749.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.